An analyst's rather bullish initiation of coverage shone a light on Lexicon Pharmaceuticals ( LXRX -1. 10% ) stock on Monday.
Read the original report for the complete account of this story.
POLARIS INSIGHTS

Read the original report for the complete account of this story.